Access cutting-edge lung cancer treatment through this clinical trial at a research site in Decatur. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Decatur at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
The purpose of ARTEMIDE-Lung04 is to assess the efficacy and safety of rilvegostomig compared with pembrolizumab monotherapy as 1L treatment in participants with mNSCLC and whose tumors express PD-L1.
Sponsor: AstraZeneca
Check if you qualify for this lung cancer clinical trial in Decatur, IL
If you're searching for lung cancer treatment options in Decatur, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Decatur research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.